WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005063217) ORAL MEDICAMENT DELIVERY SYSTEM COMPRISING COLLAGEN-BASED FIBROUS MATRIX
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/063217    International Application No.:    PCT/US2004/042814
Publication Date: 14.07.2005 International Filing Date: 17.12.2004
IPC:
A61K 9/00 (2006.01), A61K 9/20 (2006.01), A61K 9/70 (2006.01)
Applicants: PEDIAMED PHARMACEUTICALS, INC. [US/US]; 7310 Turfway Road, Suite 490, Florence, KT 41042 (US) (For All Designated States Except US).
GONZALES, Gilbert, R. [US/US]; (US) (For US Only).
HUGHES, Kenneth, E. [US/US]; (US) (For US Only).
GONZALES, Sofia, O. [US/US]; (US) (For US Only)
Inventors: GONZALES, Gilbert, R.; (US).
HUGHES, Kenneth, E.; (US).
GONZALES, Sofia, O.; (US)
Agent: SUMME, Kurt, A.; Wood, Herron & Evans, L.L.P., 2700 Carew Tower, Cincinnati, OH 45202 (US)
Priority Data:
10/741,873 19.12.2003 US
Title (EN) ORAL MEDICAMENT DELIVERY SYSTEM COMPRISING COLLAGEN-BASED FIBROUS MATRIX
(FR) SYSTEME D'ADMINISTRATION DE MEDICAMENT PAR VOIE ORALE COMPRENANT UNE MATRICE FIBREUSE A BASE DE COLLAGENE
Abstract: front page image
(EN)Oral medicament delivery system comprising a pharmaceutical composition (60) comprising a flexible matrix, said matrix formed of a plurality of fibers comprising a collagen-based carrier (44) and a medicament (59), the composition (60) orally dissolvable to deliver a unit dose of the medicament (50) to a patient. The flexible composition (60) can be dose titrated and co-administered with a second pharmaceutical formulation.
(FR)L'invention concerne un système d'administration de médicament par voie orale, qui présente une composition pharmaceutique (60) comprenant une matrice souple constituée de plusieurs fibres contenant un support à base de collagène (44) et un médicament (59). La composition se dissout dans la bouche d'un patient pour libérer une dose du médicament (50). La composition souple (60) de l'invention peut être dosée et coadministrée avec une seconde formulation pharmaceutique.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)